<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of the clinical manifestations and classification of spondyloarthritis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of the clinical manifestations and classification of spondyloarthritis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of the clinical manifestations and classification of spondyloarthritis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Astrid van Tubergen, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joachim Sieper, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Philip Seo, MD, MHS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 03, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H26417729">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term spondyloarthritis (SpA) is used for a family of disorders, including ankylosing spondylitis (AS, radiographic axial spondyloarthritis [r-axSpA]), nonradiographic axial spondyloarthritis (nr-axSpA), forms of arthritis associated with psoriasis and with inflammatory bowel diseases, and other conditions. The different forms of SpA share a group of clinical features; the most distinguishing features are inflammation of axial joints (especially the sacroiliac [SI] joints), asymmetric oligoarthritis (especially of the lower extremities), dactylitis (sausage digits), and enthesitis (inflammation at sites of ligamentous or tendon attachment to bone). Compared with the general population, patients with SpA have higher frequencies of the human leukocyte antigen (HLA) B27, and of sacroiliitis by radiography or magnetic resonance imaging (MRI) [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Major musculoskeletal features'
         </a>
         below and
         <a class="local">
          'Laboratory findings'
         </a>
         below and
         <a class="local">
          'Imaging'
         </a>
         below.)
        </p>
        <p>
         Additional features include skin and genital lesions, eye and bowel inflammation, an association with preceding or ongoing infectious disorders, positive family history, and elevated acute phase reactants [
         <a href="#rid2">
          2-5
         </a>
         ]. Other terms that have been used for this family of arthritis are spondyloarthritides, spondyloarthropathy, and spondyloarthropathies.
        </p>
        <p>
         An overview of the clinical manifestations and the classification of SpA in adults will be presented here. The clinical manifestations and diagnosis of AS and nr-axSpA, psoriatic arthritis, reactive arthritis (formerly called Reiter's syndrome), and SpA in children are discussed separately, as is an overview of peripheral SpA. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">
          "Spondyloarthritis in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417735">
         <span class="h1">
          FORMS OF SPONDYLOARTHRITIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The spondyloarthritis (SpA) family consists of the following members, which can be classified further according to the distribution of joint involvement as being predominantly axial (axial SpA) or peripheral (peripheral SpA):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ankylosing spondylitis (AS, radiographic axial SpA [r-axSpA]) (see
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonradiographic axial SpA (nr-axSpA) (see
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Nomenclature and classification'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peripheral SpA (see
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SpA associated with psoriasis or psoriatic arthritis (see
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SpA associated with Crohn disease and ulcerative colitis (see
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reactive arthritis (see
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Juvenile-onset SpA (see
         <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">
          "Spondyloarthritis in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         The reasons for the classification of SpA into these categories are both historical and practical, but each category does not necessarily represent a discrete entity, and the clinical, laboratory, and imaging findings can overlap [
         <a href="#rid3">
          3
         </a>
         ]. The diagnosis and management approaches for patients suspected of having any type of SpA are also generally similar [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         Axial SpA patients with definite radiographic sacroiliitis are conventionally diagnosed with AS, while patients with axial SpA who do not show radiographic changes of sacroiliitis or have only very mild changes are classified as having nr-axSpA [
         <a href="#rid8">
          8
         </a>
         ]. Patients with nr-axSpA were formerly included in a category termed "undifferentiated SpA" (USpA), but are generally considered clinically, diagnostically, and for management purposes together with patients with AS [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         The smaller number of patients with predominantly peripheral manifestations of SpA (eg, arthritis, enthesitis, and dactylitis, rather than predominantly back and spine pain) who do not meet established classification criteria for AS, reactive arthritis, psoriatic arthritis, or SpA related to inflammatory bowel disorders can be considered as having peripheral SpA, but often evolve to develop a specific diagnosis [
         <a href="#rid5">
          5,10
         </a>
         ]. By contrast, on follow-up, patients with axial SpA seldom switch to become peripheral SpA [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         .)
        </p>
        <p>
         Historically, the term "Reiter's syndrome" was often used to refer either to reactive arthritis or patients with a subset of features seen in some patients with reactive arthritis, including the triad of arthritis, conjunctivitis, and urethritis; the term "reactive arthritis" is preferred for practical and historical reasons and encompasses these patients as well [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417741">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is considerable variation in the prevalence of spondyloarthritis (SpA) reported worldwide, depending upon the genetic background in the country or region under study, and to a certain extent upon the criteria used by the surveyors. The prevalences of ankylosing spondylitis (AS) have been reported in Europe as between 0.12 and 1.0 percent, dependent also on the human leukocyte antigen (HLA) B27 background prevalence, and as 0.17 percent in Asia, 0.1 percent in Latin America, and 0.07 percent in Africa. The prevalence for the whole group of axial SpA has been estimated to be two to three times higher than that of AS alone [
         <a href="#rid12">
          12,13
         </a>
         ]. The low prevalence of AS in Latin America and Africa is partly because those are the regions with lowest prevalence of HLA-B27 [
         <a href="#rid14">
          14,15
         </a>
         ]. AS and nonradiographic axial SpA (nr-axSpA) are the most frequent types of SpA. In the United States, they each have a prevalence of approximately 0.35 percent [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         The male to female ratio is 2:1 in AS and 1:1 in nr-axSpA [
         <a href="#rid2">
          2
         </a>
         ], but there is a frequent delay in diagnosis in females [
         <a href="#rid4">
          4
         </a>
         ]. In contrast to axSpA, the sex distribution in peripheral SpA is equal between males and females [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         The prevalence rate for SpA is approximately 0.9 to 1.7 percent, peripheral SpA accounting for approximately 25 percent of the total [
         <a href="#rid5">
          5
         </a>
         ]. Reactive arthritis is the least common form of SpA. The epidemiologic characteristics of the individual forms of SpA are described in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Epidemiology and relation of arthritis to skin disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Prevalence'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417747">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major clinical features which differentiate spondyloarthritis (SpA) from other forms of arthritis are the distribution and type of musculoskeletal manifestations and certain extraarticular features. Patients with axial SpA characteristically have chronic low back pain. Patients with peripheral SpA can exhibit peripheral musculoskeletal features, which include dactylitis (sausage digits), enthesitis (heel pain and/or swelling), and peripheral arthritis. Patients with peripheral SpA may experience one or more of these peripheral manifestations concurrently or in the past. Patients can also have both axial and peripheral manifestations.
        </p>
        <p>
         Certain extra-musculoskeletal manifestations can be associated with the musculoskeletal features seen in SpA, including uveitis, psoriasis, features of inflammatory bowel diseases, and others. Reactive arthritis is sometimes associated with genital lesions.
        </p>
        <p class="headingAnchor" id="H26417753">
         <span class="h2">
          Major musculoskeletal features
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low back pain/inflammatory back pain
         </strong>
         – Back pain that is chronic and almost constant is one of the cornerstones of axial SpA. Patients with axial SpA typically have chronic low back pain of more than three months' duration; in most axial SpA patients, the onset of low back pain is before age 45. However, chronic low back pain of all causes, especially mechanical or nonspecific back pain, is common, with a prevalence estimated at about 20 percent of the general population [
         <a href="#rid17">
          17
         </a>
         ]; only a small minority of these individuals has axial SpA. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A combination of low back pain features designated as "inflammatory back pain" is present in 70 to 80 percent of patients with axial SpA. These features include an insidious onset, most often before the age of 40 years; improvement with exercise but not with rest; and pain at night. However, inflammatory low back pain is also observed in 20 to 25 percent of back pain from other causes [
         <a href="#rid18">
          18
         </a>
         ]. In addition, in a review of 10 years of records of 124 patients with new-onset inflammatory back pain, the probability of having SpA was only 30 percent [
         <a href="#rid19">
          19
         </a>
         ]. Thus, despite its prevalence among patients with AS, only a minority of individuals with symptoms characteristic of inflammatory back pain will have SpA, and the lack of typical features of inflammatory back pain does not exclude axial SpA in a chronic back pain patient [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Low back pain and neck pain'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         An additional feature of low back pain in some patients with axial SpA is a good response to treatment with a nonsteroidal antiinflammatory drug (NSAID). Patients with back pain of many causes may improve somewhat when treated with an NSAID, but marked improvement in pain within 24 to 48 hours is more typical of SpA [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Peripheral arthritis
         </strong>
         – Peripheral arthritis occurs at some point in approximately 37 percent of patients with axial SpA and 79 percent of patients with peripheral SpA [
         <a href="#rid22">
          22
         </a>
         ]. The peripheral arthritis in SpA often predominantly involves the lower extremities, especially the knees and ankles, and is associated with swelling [
         <a href="#rid23">
          23
         </a>
         ]. Arthritis is frequently asymmetrical and often affects only one to three joints [
         <a href="#rid24">
          24
         </a>
         ]. The severity ranges from mild to disabling [
         <a href="#rid25">
          25
         </a>
         ]. When compared with other rheumatic diseases, the sensitivity and specificity of asymmetric oligoarthritis for SpA are 41 and 87 percent, respectively [
         <a href="#rid23">
          23
         </a>
         ]. Thus, the presence of asymmetrical oligoarthritis is very suggestive of SpA, but its absence would not be helpful in excluding this possibility.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Enthesitis (enthesopathy)
         </strong>
         – Enthesitis (or enthesopathy) refers to inflammation around the enthesis, which is the site of insertion of ligaments, tendons, joint capsule, or fascia to bone, and is relatively specific to SpA [
         <a href="#rid26">
          26
         </a>
         ]. The enthesis is composed of dense collagen, fibrocartilage, adjacent bursae, and synovial folds [
         <a href="#rid26">
          26
         </a>
         ]. Enthesitis occurs at some point in the disease course in approximately 32 percent of patients with axial SpA and 63 percent of patients with peripheral SpA [
         <a href="#rid4">
          4,22
         </a>
         ]. The most common observable clinical manifestation of enthesitis is swelling at the heels, at the insertion of the Achilles tendon  (
         <a class="graphic graphic_figure graphicRef81198" href="/z/d/graphic/81198.html" rel="external">
          figure 1
         </a>
         ), or at the insertion of the plantar fascia ligament into the calcaneus [
         <a href="#rid23">
          23
         </a>
         ]. It is usually associated with severe pain and tenderness. During physical examination, the patient with plantar fasciitis may have difficulty walking on the heels when barefoot. Swelling at the site of the Achilles tendon can be appreciated when the patient is observed in the standing position from behind; however, visible changes are not always present. On palpation, there is tenderness at the sites of insertion of the Achilles tendon and/or of the plantar fascia on the calcaneus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other sites of enthesitis which are often not swollen but which can be painful and/or tender include those at the patellae, iliac crests, greater trochanters, epicondyles at the elbows, tibial plateaus, costochondral junctions at the sternum, humeral tuberosities, manubrial-sternal joints, occiput, and spinous processes [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dactylitis (sausage digits)
         </strong>
         – A characteristic feature of SpA, especially psoriatic arthritis and occasionally reactive arthritis, is dactylitis, also known as sausage toe or sausage finger  (
         <a class="graphic graphic_picture graphicRef61696" href="/z/d/graphic/61696.html" rel="external">
          picture 1
         </a>
         ). Unlike synovitis, in which swelling is confined to the joints, with dactylitis, the entire digit is swollen. Joints do not show the discrete palpable fusiform swelling of synovitis, and there may be surprisingly little pain or tenderness. The diffuse swelling arises from flexor tendon, sheath, and marked adjacent soft tissue involvement, but may also involve the bone and joints. Dactylitis occurs in only 5 percent of patients with axial SpA and 17 percent of patients with peripheral SpA [
         <a href="#rid22">
          22
         </a>
         ]. Dactylitis is not specific for SpA and may also be seen when the digits are involved with tuberculosis, syphilis, sarcoidosis, sickle cell disease, and tophaceous gout [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other musculoskeletal features
         </strong>
         – Approximately 35 to 50 percent of axial SpA patients experience anterior chest wall pain from involvement of the manubriosternal, sternoclavicular, and costosternal joints [
         <a href="#rid29">
          29
         </a>
         ]. Additional musculoskeletal features sometimes but not always seen in patients with SpA include pain in the neck, dorsal kyphosis, head-forward posture, and limitation in ranges of motion of lumbar and cervical spines and chest expansion. These are relatively nonspecific and either absent or also seen in other diseases. Limitation of ranges of motion of the spine, for example, depend on the duration of disease, disease activity, extent of structural damage, and age [
         <a href="#rid30">
          30-32
         </a>
         ]. Pain that alternates between the left and the right gluteal regions is more specific to axial SpA.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H48809459">
         <span class="h2">
          Major extra-musculoskeletal features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major extra-musculoskeletal features are uveitis, associated inflammatory bowel diseases, and psoriasis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory eye disease
         </strong>
         – Several forms of ocular inflammatory disease can be associated with SpA, including conjunctivitis and anterior uveitis [
         <a href="#rid33">
          33,34
         </a>
         ]. Conjunctivitis is typically non-purulent and transient, with symptoms subsiding within a few weeks. A more serious problem is anterior uveitis (iritis) [
         <a href="#rid34">
          34
         </a>
         ]. Uveitis, which is usually anterior uveitis, occurs in up to 30 percent of patients with SpA, and becomes recurrent in approximately 50 percent of affected patients [
         <a href="#rid35">
          35
         </a>
         ]. The initial attack is usually acute and unilateral and may be the presenting problem. Patients complain of redness, pain, and photophobia. Uveitis may be the first problem to require medical evaluation and should alert clinicians to the possibility of SpA. About 20 to 50 percent of patients with acute recurrent unilateral anterior uveitis have a form of SpA that might have been previously undiagnosed until the appearance of uveitis. Many patients with initial attacks of uveitis are not aware of the possibility of SpA [
         <a href="#rid36">
          36,37
         </a>
         ]. Although ocular inflammation usually responds to topical therapy, 10 percent can become chronic and threaten permanent impairment of vision [
         <a href="#rid38">
          38,39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5592.html" rel="external">
          "Uveitis: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         An accurate diagnosis of uveitis requires slit-lamp examination by an ophthalmologist or other expert in uveitis. Episodes of uveitis do not necessarily parallel the course of the musculoskeletal manifestations such as back pain, peripheral arthritis, or enthesitis. (See
         <a class="medical medical_review" href="/z/d/html/5581.html" rel="external">
          "Uveitis: Etiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammation of the bowel mucosa
         </strong>
         – SpA is associated with the presence of the inflammatory bowel diseases Crohn disease and ulcerative colitis. In a systematic review. the pooled prevalence of inflammatory bowel disease among patients with ankylosing spondylitis (AS) was 6.8 percent [
         <a href="#rid40">
          40
         </a>
         ]. Conversely, SpA musculoskeletal symptoms are the most common extraintestinal symptoms in patients with inflammatory bowel disease [
         <a href="#rid35">
          35,41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psoriasis
         </strong>
         – Psoriasis is associated with all forms of SpA. Some experts have suggested that all forms of arthritis associated with psoriasis should be classified as part of the SpA family, but this remains a matter of debate [
         <a href="#rid3">
          3,42
         </a>
         ]. Psoriasis is present in up to approximately 10 percent of patients with AS [
         <a href="#rid40">
          40,43
         </a>
         ]. In patients with AS, it was found that peripheral joint involvement and dactylitis are more frequently seen with concomitant psoriasis, and the disease course may be more severe than in patients without psoriasis [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4132491952">
         <span class="h2">
          Family history
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among patients with chronic back pain suspected of axial SpA, fulfillment of Assessment of SpondyloArthritis International Society (ASAS) criteria for axial SpA was more common in those with a positive family history of either ankylosing spondylitis or acute anterior uveitis in a first- or second-degree relative [
         <a href="#rid35">
          35,45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H26417801">
         <span class="h1">
          LABORATORY FINDINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although not absolutely specific for spondyloarthritis (SpA), human leukocyte antigen (HLA) B27 is a very important laboratory test in assessing SpA. Also helpful, but to a lesser extent, are acute phase reactants.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          HLA-B27
         </strong>
         – In most ethnic groups, 85 to 95 percent of patients with ankylosing spondylitis (AS) and 75 to 85 percent of patients with other forms of SpA are positive for HLA-B27 [
         <a href="#rid35">
          35
         </a>
         ]. In that way, it is a cornerstone of the diagnosis of SpA. HLA-B27 testing is frequently obtained in patients suspected of SpA; however, a positive HLA-B27 by itself is not diagnostic of SpA, since a significant proportion of subjects in the general population are also positive [
         <a href="#rid10">
          10,21,46
         </a>
         ]. Conversely, a negative HLA-B27 does not exclude a diagnosis of SpA. However, a diagnosis of axial SpA should be doubted if both HLA-B27 and imaging (including MRI) for sacroiliitis are negative. The diagnosis of SpA is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Laboratory testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults", section on 'Laboratory findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute phase response
         </strong>
         – Acute phase responses, including the erythrocyte sedimentation rate (ESR) and levels of C-reactive protein (CRP), are increased in between 35 and 50 percent of patients with axial SpA [
         <a href="#rid47">
          47,48
         </a>
         ] (see
         <a class="local">
          'Axial SpA'
         </a>
         below). Elevated levels of CRP are also a predictor of radiographic progression [
         <a href="#rid49">
          49
         </a>
         ] and for a good response to tumor necrosis factor (TNF)-blocker therapy [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26417825">
         <span class="h1">
          IMAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging is a cornerstone in the diagnosis of axial spondyloarthritis (SpA). There are several characteristic imaging findings that may be seen in patients with axial SpA. Sacroiliitis, especially on plain radiography, is relatively specific for axial SpA. Typical syndesmophytes and other changes of spondylitis in the spine are also relatively specific for axial SpA, but are usually seen in more longstanding disease and are not often present early in the disease course. Other findings may include changes of enthesitis and erosive joint disease, but are not specific to axial SpA. In some patients with peripheral SpA, evidence for sacroiliitis can also be found, even if these patients do not complain of back pain [
         <a href="#rid51">
          51
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Musculoskeletal imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults", section on 'Imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis", section on 'Imaging abnormalities'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417831">
         <span class="h2">
          Plain radiographs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many patients with axial involvement have normal plain radiographs in early disease, although the presence of radiographic findings consistent with definite sacroiliitis strongly suggests a diagnosis of axial SpA. Plain radiographs of the spine, involved peripheral joints, and entheses may demonstrate abnormalities in longstanding axial SpA [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults", section on 'Imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis", section on 'Imaging abnormalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Radiography'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417837">
         <span class="h3">
          Axial radiographs
         </span>
         <span class="headingEndMark">
          —
         </span>
         The only plain radiographic findings that are specific for axial SpA are those of sacroiliitis. However, it may take several years from the onset of disease before radiographic sacroiliitis becomes apparent. Only in less than 5 percent of ankylosing spondylitis (AS) patients, AS-typical syndesmophytes, ossification originating from the intervertebral ligaments that may bridge the vertebral bodies, may be found in the spine in the absence of radiographic sacroiliitis. At least 50 percent of patients with AS develop syndesmophytes of the spine in the course of their disease. These syndesmophytes have a typical appearance and are easily differentiated from degenerative spinal osteophytes. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Spine'
         </a>
         .)
        </p>
        <p>
         Plain radiographs of the sacroiliac (SI) joints can be semiquantitatively graded based upon the presence of the characteristic radiographic findings [
         <a href="#rid52">
          52
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Plain radiography'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 0: Normal  (
         <a class="graphic graphic_diagnosticimage graphicRef63078" href="/z/d/graphic/63078.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 1: Suspicious changes  (
         <a class="graphic graphic_diagnosticimage graphicRef56285" href="/z/d/graphic/56285.html" rel="external">
          image 2
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 2: Minimal abnormality – Small localized areas with erosions or sclerosis, without alteration in the joint width  (
         <a class="graphic graphic_diagnosticimage graphicRef56285" href="/z/d/graphic/56285.html" rel="external">
          image 2
         </a>
         ). Erosions usually first appear on the iliac side.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 3: Unequivocal abnormality – Moderate or advanced sacroiliitis with erosions, evidence of sclerosis, widening, narrowing, or partial ankylosis  (
         <a class="graphic graphic_diagnosticimage graphicRef68009 graphicRef79174" href="/z/d/graphic/68009.html" rel="external">
          image 3A-B
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 4: Severe abnormality – Total ankylosis  (
         <a class="graphic graphic_diagnosticimage graphicRef58791 graphicRef70511" href="/z/d/graphic/58791.html" rel="external">
          image 4A-B
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         According to these grading criteria, a patient is regarded as positive for evidence of radiographic sacroiliitis if the radiographic study is rated at grade 2 or higher bilaterally, or at grade 3 or higher unilaterally [
         <a href="#rid52">
          52
         </a>
         ]. By convention among experts, nearly all patients considered to have nonradiographic axial SpA (nr-axSpA) do not have definite plain radiographic findings of sacroiliitis [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         Radiographic sacroiliitis is considered the hallmark of AS, but whether it should continue to be used as a diagnostic criterion is a matter of debate. It is frequently absent in the first year of the disease, and a substantial proportion of the patients with axial SpA will never develop it [
         <a href="#rid54">
          54
         </a>
         ]. Furthermore, disagreement among radiologists or rheumatologists reading the same film is frequent, resulting in false-positive or false-negative diagnoses of AS, and additional training does not improve recognition of sacroiliitis. The highest variability is observed in the evaluation of grades 1 and 2 [
         <a href="#rid55">
          55,56
         </a>
         ]. Further investigation is needed to determine whether MRI-T1 sequences or low-dose computed tomography (CT) can substitute for radiographs for the detection of structural lesions in the SI joint, as was suggested in one study [
         <a href="#rid57">
          57,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H466338331">
         <span class="h3">
          Radiographs of peripheral joints and entheses
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is some variation in the degree and type of radiographic change seen in different types of SpA. In patients with axial SpA, the most severe peripheral joint involvement observed on plain radiographs is in the hip joints, where extensive destructive changes may occur. By contrast, although the knees might show considerable swelling, sometimes persistent for years, radiographs of the knees in patients with SpA often show only mild osteoarthritic changes [
         <a href="#rid59">
          59
         </a>
         ]. Similarly, radiographic changes in the shoulders are usually only minor in patients with AS [
         <a href="#rid60">
          60
         </a>
         ]. Fluffy erosions can sometimes be seen in areas of enthesitis, such as the heels, although these findings are not specific for SpA [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Plain radiography'
         </a>
         .)
        </p>
        <p>
         Radiographic changes in peripheral joints are common in patients with psoriatic arthritis, even relatively early in the disease course [
         <a href="#rid62">
          62,63
         </a>
         ]. Changes can develop in the course of psoriatic arthritis that exhibit a pattern usually not seen in other forms of inflammatory arthritis of coexisting erosive changes and new bone formation within the same joint or in different joints within the same digit. Other typical changes include lysis of the terminal phalanges; fluffy periostitis, as well as new bone formation, at the site of enthesitis; gross destruction of isolated joints; "pencil-in-cup" appearance; and the occurrence of both joint lysis and ankylosis in the same patient  (
         <a class="graphic graphic_diagnosticimage graphicRef58709" href="/z/d/graphic/58709.html" rel="external">
          image 5
         </a>
         ) [
         <a href="#rid62">
          62,64
         </a>
         ]. Patients with psoriatic arthritis may exhibit more damage at the knees than patients with other forms of SpA. (See
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'
         </a>
         .)
        </p>
        <p>
         In patients with arthritis associated with inflammatory bowel disease, plain film radiographs of the peripheral joints demonstrate soft-tissue swelling, juxtaarticular osteoporosis, mild periostitis, and effusions, usually without erosions or destruction. Radiographic abnormalities in the joints are common, even in asymptomatic patients. (See
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Radiographic findings'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417849">
         <span class="h2">
          Magnetic resonance imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRI can reveal changes consistent with SpA, including sacroiliitis and spinal changes, but is usually not necessary for diagnostic purpose in patients with obvious abnormalities on plain radiography. MRI abnormalities of the SI joints in the face of normal plain radiographs are important in helping to establish the diagnosis of nr-axSpA. (See
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Spine'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'MRI of sacroiliac joints'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417855">
         <span class="h3">
          MRI of sacroiliac joints
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most prominent SI joint findings on MRI that are characteristic of SpA are high-intensity bone marrow edema (BME) on short tau inversion recovery (STIR) or on T2 with fat absorption images. Typical locations are the subchondral or periarticular bone marrow  (
         <a class="graphic graphic_diagnosticimage graphicRef74986" href="/z/d/graphic/74986.html" rel="external">
          image 6
         </a>
         ) [
         <a href="#rid58">
          58
         </a>
         ]. Specific definitions for active sacroiliitis have been formulated for use with some classification criteria. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'MRI of sacroiliac joints'
         </a>
         .)
        </p>
        <p>
         BME becomes especially important when associated with structural lesions, such as fat metaplasia, sclerosis, erosions, backfill (fat metaplasia in the joint space), or bony ankylosis [
         <a href="#rid65">
          65,66
         </a>
         ].
        </p>
        <p>
         Although BME in the SI joint is suggestive of axial SpA, it can also be seen in healthy subjects as well as in postpartum women, and individuals with other diseases such as infection, malignancy, and osteitis condensans ilii [
         <a href="#rid3">
          3,66
         </a>
         ]. In addition, for the same MRI, there can be discrepancy among different readers. However, when MRI findings are interpreted together with clinical findings, the discrepancies do not affect the clinical decisions [
         <a href="#rid67">
          67
         </a>
         ]. The use and importance of MRI of the SI joints in the diagnosis of axial SpA is discussed in detail separately [
         <a href="#rid68">
          68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'MRI of sacroiliac joints'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26417861">
         <span class="h3">
          MRI of the spine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical spondylitis-related MRI lesions are triangular in shape and are located at one or more of the four corners of the vertebrae. They include BME observed with the STIR or the T2 with fat absorption sequences, as well as fatty deposits observed as high-intensity lesions in the T1-weighted sequences. Again, such findings are not specific for SpA [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Spine'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H52903950">
         <span class="h2">
          Other imaging techniques
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other imaging techniques are less frequently used.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ultrasonography for enthesitis
         </strong>
         – The ultrasonographic features of enthesitis include inflammation (hypoechogenicity, increased thickness of the tendon insertion, and Doppler activity) and structural changes (intratendinous calcifications and enthesophytes) [
         <a href="#rid70">
          70
         </a>
         ].Although ultrasound might detect the inflammatory changes of sacroiliitis, its use is presently limited to research and is not recommended in routine clinical practice [
         <a href="#rid71">
          71
         </a>
         ]. The findings and use of ultrasonography in SpA and other conditions are described in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1832.html" rel="external">
          "Musculoskeletal ultrasonography: Clinical applications", section on 'Entheses'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Imaging of enthesitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Nomenclature and classification'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          CT scanning
         </strong>
         – CT is more sensitive than plain radiography for the detection of structural changes in the sacroiliac joints [
         <a href="#rid72">
          72
         </a>
         ]. However, CT scanning has several disadvantages compared with MRI. CT and MRI are comparable for the detection of bony changes such as erosions and sclerosis, but only MRI allows detection and analysis of inflammatory changes in subchondral bone and entheses (STIR sequence), as well as the detection of fatty change (T1 sequence) [
         <a href="#rid73">
          73,74
         </a>
         ]. Moreover, radiation exposure from CT studies is a clear disadvantage compared with MRI. This might be overcome in the future with low-dose CT [
         <a href="#rid57">
          57,58,75-77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Scintigraphy
         </strong>
         – Bone scintigraphy reveals high uptake in areas of inflammation. However, it is too nonspecific to be useful for diagnosis of SpA [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Imaging studies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H99109356">
         <span class="h1">
          CLASSIFICATION OF SPONDYLOARTHRITIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Classification criteria for spondyloarthritis (SpA) in general and ankylosing spondylitis (AS) specifically were developed for use in epidemiologic and clinical research such as clinical drug trials; similar to other rheumatic diseases [
         <a href="#rid79">
          79
         </a>
         ], they do not have sufficient sensitivity and specificity for use as the only diagnostic tools in clinical practice and thus cannot be regarded in clinical practice as inviolable rules [
         <a href="#rid54">
          54,80,81
         </a>
         ]. The classification criteria developed by the Assessment of SpondyloArthritis International Society (ASAS) are broadly inclusive, used widely by experts in SpA, and distinguish between axial and peripheral SpA (see
         <a class="local">
          'ASAS classification criteria'
         </a>
         below). Use of the ASAS criteria has largely replaced the use of older classification criteria, including the Modified New York criteria for AS, the European Spondyloarthritides Study Group (ESSG) criteria, and the Amor criteria, among SpA investigators [
         <a href="#rid23">
          23,82,83
         </a>
         ]. (See
         <a class="local">
          'Other SpA classification criteria'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H26417909">
         <span class="h2">
          ASAS classification criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are two sets of classification criteria for SpA that have been issued by the ASAS: one for those presenting with axial involvement (see
         <a class="local">
          'Axial SpA'
         </a>
         below), published in 2009, and the other for those presenting with peripheral involvement (see
         <a class="local">
          'Peripheral SpA'
         </a>
         below), published in 2011 [
         <a href="#rid52">
          52
         </a>
         ]. The classification criteria were generated from a cross-sectional study of patients newly referred for possible SpA and of control arthritis patients. In the ASAS study population, in patients (largely) who were under age 45 and who presented with either undiagnosed back pain or peripheral arthritis (or enthesitis or dactylitis) at the time seen, the combined criteria had a sensitivity of 80 percent and a specificity of 83 percent [
         <a href="#rid24">
          24
         </a>
         ]. These criteria compared favorably with other previously established criteria sets. (See
         <a class="local">
          'Other SpA classification criteria'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H26417915">
         <span class="h3">
          Axial SpA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Classification criteria for axial SpA, including criteria for those without plain radiographic changes (nonradiographic axial SpA [nr-axSpA]) and with radiographic (radiographic axial SpA) changes of sacroiliitis, were based upon a large multicenter study [
         <a href="#rid47">
          47
         </a>
         ]. In patients with a history of back pain of unknown origin, which was of at least three months' duration and which began before age 45, the classification criteria for axial SpA exhibited sensitivity of 83 percent and specificity of 84 percent [
         <a href="#rid47">
          47
         </a>
         ]. This algorithm is as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The entry step is that the patient must have back pain of any type for at least three months, and the age of onset must be less than 45 years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The second step consists of two arms that are evaluated separately based upon the presence either of sacroiliitis on imaging or of human leukocyte antigen (HLA) B27:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HLA-B27-positive patients – In patients who test positive for HLA-B27, at least two additional features of SpA from the list below are required for classifying a patient as having axial SpA (see
         <a class="local">
          'SpA features'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sacroiliitis on imaging – In patients diagnosed with sacroiliitis based upon plain radiographs (structural changes) or MRI (subchondral bone marrow edema [BME]), at least one other feature of SpA from the list below should be present (see
         <a class="local">
          'SpA features'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26417921">
         <span class="h4">
          SpA features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following are SpA features that contribute to the classification criteria for axial SpA (see
         <a class="local">
          'Axial SpA'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammatory back pain – Several definitions for inflammatory back pain have been proposed. For classification purposes, inflammatory back pain can be defined as having at least four of the five following parameters [
         <a href="#rid84">
          84
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Age of onset &lt;40 years
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Insidious onset
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Improvement with exercise
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         No improvement with rest
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain at night (with improvement upon arising)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other SpA features (each of equal weight) – Other SpA features include the presence of one or more of the non-spinal features noted below. The occurrence can be either before or at the time of evaluation for the following items listed: arthritis, heel enthesitis, uveitis, dactylitis, psoriasis, and inflammatory bowel disease. The features are:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Arthritis – As diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heel enthesitis – Spontaneous pain or tenderness at site of insertion of Achilles tendon or plantar fascia at the calcaneus diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Uveitis – Confirmed by an ophthalmologist
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dactylitis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Psoriasis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory bowel disease – Crohn disease or ulcerative colitis diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Good response to nonsteroidal antiinflammatory drugs (NSAIDs) – Within 24 to 48 hours
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Family history of SpA – Presence in first- or second-degree relatives of AS or acute anterior uveitis [
         <a href="#rid45">
          45
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Elevated C-reactive protein (CRP) – After exclusion of other causes for elevated CRP
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26417927">
         <span class="h3">
          Peripheral SpA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Classification criteria for peripheral SpA were based upon analyses of data from a cross-sectional international multicenter study [
         <a href="#rid24">
          24
         </a>
         ]. In patients with undiagnosed peripheral arthritis, enthesitis, and/or dactylitis, the ASAS classification criteria for peripheral SpA had a sensitivity of 78 percent and a specificity of 83 percent [
         <a href="#rid24">
          24
         </a>
         ]. In the study, 85 percent of the patients were under age 45. For classification as having peripheral SpA, the patient should NOT have concurrent chronic (inflammatory) back pain. In that case, the axial SpA criteria should be used. However, inflammatory back pain in the past is considered as a contributing SpA feature. There are two steps in the algorithm for classifying peripheral SpA:
        </p>
        <p>
         The entry step is that the patient should have, at the time of being seen, at least one of the following three findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enthesitis (spontaneous pain or tenderness at any enthesis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dactylitis
        </p>
        <p>
        </p>
        <p>
         If the patient satisfies the entry criteria, the patient should show (or have had in the past) at least one of the features of SpA in Group A (below) or at least two of the features of SpA in group B (below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Group A SpA features:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Uveitis – Confirmed by an ophthalmologist
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Psoriasis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Crohn disease or ulcerative colitis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preceding infection – Urethritis/cervicitis or diarrhea within one month prior to onset of arthritis/enthesitis/dactylitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HLA-B27
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sacroiliitis on imaging
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Group B SpA features:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Arthritis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Enthesitis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dactylitis – Diagnosed by a clinician
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory back pain in the past
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Family history of SpA – Presence in first- or second-degree relatives of AS and acute uveitis
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26417945">
         <span class="h2">
          Other SpA classification criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Research prior to the 2009 and 2011 publication of the ASAS criteria (see
         <a class="local">
          'ASAS classification criteria'
         </a>
         above) usually classified patients using either the ESSG criteria, the Amor criteria, or the modified New York Criteria for AS [
         <a href="#rid23">
          23,82,83
         </a>
         ]. These criteria sets differ somewhat from each other and from the ASAS classification criteria  (
         <a class="graphic graphic_table graphicRef96419" href="/z/d/graphic/96419.html" rel="external">
          table 1
         </a>
         ). The ESSG and Amor criteria cover the whole spectrum of SpA and include a broader range of manifestations of SpA compared with the modified New York criteria. However, unlike the ASAS classification criteria, these criteria do not differentiate axial from peripheral disease, a distinction that may be important for providing optimal care and for testing treatment strategies, and MRI findings are not taken into consideration. Because certain medications have been approved by the US Food and Drug Administration (FDA) for AS alone, the Modified New York criteria for AS still play a role in decision making [
         <a href="#rid81">
          81
         </a>
         ]. Patients fulfilling these criteria are largely overlapping with radiographic axial SpA (as part of axial SpA), with identical definitions for the radiographic changes in the SI-joints, but with some differences in the definition of the nonimaging parameters:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          1984 Modified New York Criteria
         </strong>
         – For most research carried out from the mid-1980s to 2009, patients were regarded as having AS only if they fulfilled the 1984 Modified New York Criteria for AS. However, these criteria do not recognize patients with nonradiographic axial SpA (nr-axSpA), because such patients lack radiographic sacroiliitis, one of the required criteria. The modified New York criteria consist of a subset of clinical parameters and a subset of radiological parameters, with a patient regarded as having definite AS if they fulfill at least one radiologic parameter plus at least one clinical parameter:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Clinical parameters
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Low back pain and stiffness for more than three months that improves with exercise but that is not relieved by rest
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Limitation of motion of the lumbar spine in both the sagittal and frontal planes
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Limitation of chest expansion relative to normal values correlated for age and sex
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Radiological parameters using plain radiographs alone (see
         <a class="local">
          'Axial radiographs'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Sacroiliitis grade ≥2 bilaterally, or
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Sacroiliitis grade 3 to 4 unilaterally
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4002223882">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118770.html" rel="external">
          "Society guideline links: Spondyloarthritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26418041">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/518.html" rel="external">
          "Patient education: Reactive arthritis (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/577.html" rel="external">
          "Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26418047">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spondyloarthritis (SpA) refers to a group of diseases that share the combination of several major clinical features. The most important features are chronic low back pain, positivity with the blood test for the human leukocyte antigen (HLA) B27, and radiographic or MRI changes in the sacroiliac (SI) joints in patients with axial SpA; and (oligo)arthritis, heel enthesitis and dactylitis in patients with peripheral SpA. Additional characteristics include a good response to nonsteroidal antiinflammatory drugs (NSAIDs), a positive family history for SpA, uveitis, inflammatory bowel disease, psoriasis, and increased levels of acute phase reactants. (See
         <a class="local">
          'Forms of spondyloarthritis'
         </a>
         above and
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="local">
          'Laboratory findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disorders considered as forms of SpA include ankylosing spondylitis (AS), nonradiographic axial SpA (nr-axSpA), peripheral SpA, psoriatic arthritis, inflammatory bowel disease-related arthritis, reactive arthritis (formerly called Reiter's syndrome), and SpA in children. (See
         <a class="local">
          'Forms of spondyloarthritis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Characteristic imaging findings that may be seen in patients with axial SpA include sacroiliitis, which may result in structural lesions such as sclerosis, joint space widening, or erosion, and is relatively specific for axial SpA on plain radiography; and syndesmophytes and changes of spondylitis in the spine, which are most often detected in more longstanding disease. Evidence of active sacroiliitis (subchondral bone marrow edema [BME]) on MRI in patients with normal plain radiography is very frequently seen in patients with nr-axSpA. (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sets of classification criteria for axial and peripheral SpA have been developed for epidemiologic and clinical research purposes. The Assessment of SpondyloArthritis International Society (ASAS) criteria broadly distinguish between axial SpA (AS and nr-axSpA) and peripheral SpA; the ASAS criteria are inclusive of disorders such as psoriatic arthritis or inflammatory bowel disease-related arthritis. AS, a subset of axial SpA, is defined by the Modified New York criteria for AS. (See
         <a class="local">
          'Classification of spondyloarthritis'
         </a>
         above and
         <a class="local">
          'ASAS classification criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1226099677">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges David Yu, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Sepriano A, Ramiro S, van der Heijde D, et al. What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts. Ann Rheum Dis 2020; 79:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navarro-Compán V, Sepriano A, El-Zorkany B, van der Heijde D. Axial spondyloarthritis. Ann Rheum Dis 2021; 80:1511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol 2021; 17:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walsh JA, Magrey M. Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. J Clin Rheumatol 2021; 27:e547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carron P, De Craemer AS, Van den Bosch F. Peripheral spondyloarthritis: a neglected entity-state of the art. RMD Open 2020; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeidler H, Amor B. The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis 2011; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeidler H, Calin A, Amor B. A historical perspective of the spondyloarthritis. Curr Opin Rheumatol 2011; 23:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiltz U, Baraliakos X, Karakostas P, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) 2012; 64:1415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open 2019; 5:e001108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 2005; 44:1483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panush RS, Paraschiv D, Dorff RE. The tainted legacy of Hans Reiter. Semin Arthritis Rheum 2003; 32:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakland G, Nossent HC. Epidemiology of spondyloarthritis: a review. Curr Rheumatol Rep 2013; 15:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dean LE, Jones GT, MacDonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 2014; 53:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mathieu A, Paladini F, Vacca A, et al. The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis. Autoimmun Rev 2009; 8:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan MA. Spondyloarthropathies. Curr Opin Rheumatol 1998; 10:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strand V, Rao SA, Shillington AC, et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (Hoboken) 2013; 65:1299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 2013; 345:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004; 63:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang R, Crowson CS, Wright K, Ward MM. Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study. Arthritis Rheumatol 2018; 70:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weisman MH. Inflammatory back pain: the United States perspective. Rheum Dis Clin North Am 2012; 38:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005; 52:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López-Medina C, Moltó A, Dougados M. Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study. J Rheumatol 2020; 47:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eksioglu E, Bal A, Gulec B, et al. Assessment of shoulder involvement and disability in patients with ankylosing spondylitis. Rheumatol Int 2006; 27:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Agostino MA, Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol 2006; 20:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Healy PJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr Rheumatol Rep 2006; 8:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee TH, Lee CM, Kim TH, Lee S. Anterior Chest Wall Involvement in Spondyloarthritis Patients as Detected by Magnetic Resonance Imaging: A Case Series and Literature Review. J Rheum Dis 2021; 28:159.
          </a>
         </li>
         <li class="breakAll">
          https://www.asas-group.org/app/download/11136828097/Mobility_Curves.pdf?t=1521145785 (Accessed on August 01, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramiro S, van Tubergen A, Stolwijk C, et al. Reference intervals of spinal mobility measures in normal individuals: The MOBILITY study. Ann Rheum Dis 2015; 74:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calvo-Gutierrez J, Garrido-Castro JL, Gil-Cabezas J, et al. Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation? Arthritis Care Res (Hoboken) 2015; 67:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Amayreh IA, Zaidat BO. Ankylosing spondylitis in Northern Jordan. Saudi Med J 2000; 21:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT. The eye in spondyloarthritis✰. Semin Arthritis Rheum 2019; 49:S29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayward RJ, Machado PM. Classification Criteria in Axial Spondyloarthritis: What Have We Learned; Where Are We Going? Rheum Dis Clin North Am 2020; 46:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz-Fernández S, Martín-Mola E. Uveitis. Best Pract Res Clin Rheumatol 2006; 20:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sykes MP, Hamilton L, Jones C, Gaffney K. Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI. RMD Open 2018; 4:e000553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali A, Samson CM. Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol 2007; 18:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Curr Rheumatol Rep 2013; 15:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011; 22:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edmunds L, Elswood J, Kennedy LG, Calin A. Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991; 18:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ez-Zaitouni Z, Hilkens A, Gossec L, et al. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts. Arthritis Res Ther 2017; 19:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown MA. Human leucocyte antigen-B27 and ankylosing spondylitis. Intern Med J 2007; 37:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012; 64:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Listing J, Brandt J, et al. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004; 63:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carron P, Varkas G, Cypers H, et al. Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study. Ann Rheum Dis 2017; 76:1389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 Suppl 2:ii1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rojas-Vargas M, Muñoz-Gomariz E, Escudero A, et al. First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology (Oxford) 2009; 48:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology (Oxford) 2020; 59:iv6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Tubergen A, Heuft-Dorenbosch L, Schulpen G, et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 2003; 62:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Berg R, Lenczner G, Feydy A, et al. Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort. Arthritis Rheumatol 2014; 66:2403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diekhoff T, Hermann KG, Greese J, et al. Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: Results from the SIMACT study. Ann Rheum Dis 2017; 76:1502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maksymowych WP. The role of imaging in the diagnosis and management of axial spondyloarthritis. Nat Rev Rheumatol 2019; 15:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett AN, Marzo-Ortega H, Tan AL, et al. Ten-year follow-up of SpA-related oligoarthritis involving the knee: the presence of psoriasis but not HLA-B27 or baseline MRI bone oedema predicts outcome. Rheumatology (Oxford) 2012; 51:1099.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Will R, Kennedy G, Elswood J, et al. Ankylosing spondylitis and the shoulder: commonly involved but infrequently disabling. J Rheumatol 2000; 27:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Resnick D, Feingold ML, Curd J, et al. Calcaneal abnormalities in articular disorders. Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and Reiter syndrome. Radiology 1977; 125:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA)--an analysis of 220 patients. Q J Med 1987; 62:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42:1460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siannis F, Farewell VT, Cook RJ, et al. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis 2006; 65:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jans L, Egund N, Eshed I, et al. Sacroiliitis in Axial Spondyloarthritis: Assessing Morphology and Activity. Semin Musculoskelet Radiol 2018; 22:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seven S, Østergaard M, Morsel-Carlsen L, et al. The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons. Rheumatology (Oxford) 2020; 59:3237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maksymowych WP, Pedersen SJ, Weber U, et al. Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria. Ann Rheum Dis 2020; 79:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khmelinskii N, Regel A, Baraliakos X. The Role of Imaging in Diagnosing Axial Spondyloarthritis. Front Med (Lausanne) 2018; 5:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baraliakos X, Richter A, Feldmann D, et al. Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged &lt;45 years. Ann Rheum Dis 2020; 79:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seven S, Pedersen SJ, Østergaard M, et al. Peripheral Enthesitis Detected by Ultrasonography in Patients With Axial Spondyloarthritis-Anatomical Distribution, Morphology, and Response to Tumor Necrosis Factor-Inhibitor Therapy. Front Med (Lausanne) 2020; 7:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mascarenhas S, Couette N. A Systematic Review of the Inclusion of Non-Inflammatory Ultrasonographic Enthesopathy Findings in Enthesitis Scoring Indices. Diagnostics (Basel) 2021; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devauchelle-Pensec V, D'Agostino MA, Marion J, et al. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum 2012; 64:1412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puhakka KB, Jurik AG, Egund N, et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol 2003; 44:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan S, Ward MM. Computed tomography in axial spondyloarthritis. Curr Opin Rheumatol 2018; 30:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Koning A, de Bruin F, van den Berg R, et al. Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort. Ann Rheum Dis 2018; 77:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambert RGW, Hermann KGA, Diekhoff T. Low-dose computed tomography for axial spondyloarthritis: update on use and limitations. Curr Opin Rheumatol 2021; 33:326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song IH, Carrasco-Fernández J, Rudwaleit M, Sieper J. The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research. Ann Rheum Dis 2008; 67:1535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015; 67:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collantes E, Veroz R, Escudero A, et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2000; 67:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Proft F, Poddubnyy D. Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis 2018; 10:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 1990; 57:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009; 68:784.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 95962 Version 14.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31980546" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34615639" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33361770" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Axial spondyloarthritis: concept, construct, classification and implications for therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33105312" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinical Manifestations and Diagnosis of Axial Spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32385142" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Peripheral spondyloarthritis: a neglected entity-state of the art.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21163805" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21519270" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : A historical perspective of the spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22505331" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31803500" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16091395" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12621586" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The tainted legacy of Hans Reiter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23888360" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Epidemiology of spondyloarthritis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24324212" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Global prevalence of ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19185064" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9725087" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Spondyloarthropathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23436774" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23841117" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15082484" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : How to diagnose axial spondyloarthritis early.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29471593" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23083751" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Inflammatory back pain: the United States perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15818678" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30988127" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1930310" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21109520" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16932961" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Assessment of shoulder involvement and disability in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16777577" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Enthesitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12525381" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Assessment of enthesitis in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16973106" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Dactylitis: pathogenesis and clinical considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37476000" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Anterior Chest Wall Involvement in Spondyloarthritis Patients as Detected by Magnetic Resonance Imaging: A Case Series and Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37476000" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Anterior Chest Wall Involvement in Spondyloarthritis Patients as Detected by Magnetic Resonance Imaging: A Case Series and Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24665113" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Reference intervals of spinal mobility measures in normal individuals: The MOBILITY study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25049194" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11369960" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Ankylosing spondylitis in Northern Jordan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31779847" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The eye in spondyloarthritis✰.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32340700" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Classification Criteria in Axial Spondyloarthritis: What Have We Learned; Where Are We Going?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16777578" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29531779" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15051216" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18162999" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Seronegative spondyloarthropathies and the eye.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23999006" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/957999" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23371481" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Psoriatic arthritis: phenotypic variance and nosology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22075279" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1865416" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28569222" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17908085" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Human leucocyte antigen-B27 and ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19297344" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19248087" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22127957" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15037444" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28213565" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19433414" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19208685" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33053191" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12759287" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24909765" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28283515" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: Results from the SIMACT study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31591500" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The role of imaging in the diagnosis and management of axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22328564" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Ten-year follow-up of SpA-related oligoarthritis involving the knee: the presence of psoriasis but not HLA-B27 or baseline MRI bone oedema predicts outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10648036" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Ankylosing spondylitis and the shoulder: commonly involved but infrequently disabling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/910045" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Calcaneal abnormalities in articular disorders. Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and Reiter syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3659255" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Psoriatic arthritis (PSA)--an analysis of 220 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14523223" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16126794" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Clinical and radiological damage in psoriatic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29672806" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Sacroiliitis in Axial Spondyloarthritis: Assessing Morphology and Activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32240310" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32371388" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29719835" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The Role of Imaging in Diagnosing Axial Spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31744822" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged&lt;45 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32766263" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Peripheral Enthesitis Detected by Ultrasonography in Patients With Axial Spondyloarthritis-Anatomical Distribution, Morphology, and Response to Tumor Necrosis Factor-Inhibitor Therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33917826" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : A Systematic Review of the Inclusion of Non-Inflammatory Ultrasonographic Enthesopathy Findings in Enthesitis Scoring Indices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22081446" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19454404" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12694111" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29538011" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Computed tomography in axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29127092" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33927123" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Low-dose computed tomography for axial spondyloarthritis: update on use and limitations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18230629" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25776731" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Distinctions between diagnostic and classification criteria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11195314" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29942364" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2181618" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : [Criteria of the classification of spondylarthropathies].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6231933" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19147614" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
